Novartis and GlaxoSmithKline reach settlement in Augmentin ITC lawsuit
July 10, 2003 01:42 ET | Novartis
BASEL, Switzerland, July 10, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced that its affiliate companies have reached an agreement with GlaxoSmithKline (NYSE:GSK) over lawsuits related to GSK's...
NOVARTIS logo.jpg
Novartis und GlaxoSmithKline erzielen im ITC-Prozess um Augmentin einen Vergleich
July 10, 2003 01:30 ET | Novartis Pharma AG
Basel, 10. Juli, 2003 - Wie Novartis (NSYE: NVS) bekannt gibt, haben ihre Tochtergesellschaften mit GlaxoSmithKline (NYSE: GSK) im Zusammenhang mit Prozessen um von GSK geltend gemachte...
NOVARTIS logo.jpg
Novartis and GlaxoSmithKline reach settlement in Augmentin ITC lawsuit
July 10, 2003 01:30 ET | Novartis Pharma AG
Basel, 10 July 2003 - Novartis (NSYE: NVS) announced that its affiliate companies have reached an agreement with GlaxoSmithKline (NYSE: GSK) over lawsuits related to GSK's claimed Augmentin trade...
NOVARTIS logo.jpg
Swissmedic-Zulassung für Leponex® zur Behandlung suizidalen Verhaltens bei Patienten mit Schizophrenie und schizoaffektiver Störung
July 10, 2003 01:28 ET | Novartis Pharma AG
Erste Arzneimittelzulassung für dieses Anwendungsgebiet in Europa   Basel, 10. Juli 2003 - Novartis hat heute bekannt gegeben, dass die Schweizerische Heilmittelbehörde (Swissmedic) die...
NOVARTIS logo.jpg
Swissmedic approuve Leponex® pour le traitement du comportement suicidaire chez les patients souffrant de schizophrénie ou d'un trouble schizoaffectif
July 10, 2003 01:27 ET | Novartis Pharma AG
Premier médicament à être approuvé pour cette indication en Europe à ce jour   Bâle, le 10 juillet 2003 - Novartis a annoncé aujourd'hui que l'Agence Suisse pour les Produits Thérapeutiques...
NOVARTIS logo.jpg
Swissmedic approves Leponex® to treat suicidal behaviour in patients with schizophrenia and schizoaffective disorder
July 10, 2003 01:27 ET | Novartis Pharma AG
First medication ever approved for this Indication in Europe   Basel, 10 July 2003 - Novartis announced today that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing...
'The StockHouse Search Contest' to Make Two Investors Famous - Winners to Appear in a National Ad Campaign
July 09, 2003 20:21 ET | Stockgroup Information Systems Inc.
VANCOUVER, B.C., July 9, 2003 (PRIMEZONE) -- Stockgroup Information Systems Inc. (OTCBB:SWEB) (TSX Venture Exchange:SWB), a financial media and technology company, is pleased to announce the launch...
Shareholder Class Action Filed Against Read-Rite Corporation By The Law Firm Of Schiffrin & Barroway, LLP -- RDRT, RDRTQ
July 09, 2003 18:23 ET | Schiffrin Barroway Topaz & Kessler, LLP
Bala Cynwyd, PA , July 9, 2003 (PRIMEZONE) -- The following statement was issued today by the law firm of Schiffrin & Barroway, LLP: Notice is hereby given that a class action lawsuit was...
Stockwinners.com Option Picks Average Gains of More than One Hundred Percent; Daily Stock Picks Up Twenty-Two Percent
July 09, 2003 18:09 ET | Stockwinners.com
AUSTIN, July 9, 2003 (PRIMEZONE) -- The following is an investment opinion issued by Stockwinners.com. Selections featured in recent Stockwinners.com, http://www.STOCKWINNERS.com, Option Picks...
Stockwinners.com Option Picks Average Gains of More than One Hundred Percent; Rumors Up Twenty-Eight Percent
July 09, 2003 17:55 ET | Stockwinners.com
AUSTIN, July 9, 2003 (PRIMEZONE) -- The following is an investment opinion issued by Stockwinners.com. Selections featured in recent Stockwinners.com, http://www.STOCKWINNERS.com, Option Picks...